Skip to main content
. 2022 Jun 23;10(6):e004984. doi: 10.1136/jitc-2022-004984

Figure 2.

Figure 2

─ Response and duration of response of patients treated with nivolumab. The colored bars represent time on nivolumab. CR, complete response; PR, partial response; PD, progression of disease.